Bloomage BioTechnology Corporation Limited (SHA:688363)
China · Delayed Price · Currency is CNY 55.42
+0.40 (0.73%)
Sep 30, 2025, 3:00 PM CST
SHA:688363 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 53.35 | 174.27 | 592.56 | 970.92 | 782.33 | 645.84 | Upgrade |
Depreciation & Amortization | 317.13 | 293.87 | 264.65 | 213.61 | 154.33 | 70.19 | Upgrade |
Other Amortization | 41.81 | 36.31 | 27.74 | 15.04 | 6.96 | 4.84 | Upgrade |
Loss (Gain) From Sale of Assets | 0.56 | 0.12 | 3.42 | 0.49 | -0.04 | -0.05 | Upgrade |
Asset Writedown & Restructuring Costs | 75.81 | 74.95 | 1.87 | 0.28 | 33.73 | 16.59 | Upgrade |
Loss (Gain) From Sale of Investments | 13.67 | 11.48 | 17.41 | -11.77 | -28.04 | -37.52 | Upgrade |
Provision & Write-off of Bad Debts | 25.35 | 26.01 | 7.6 | 15.36 | 5.78 | - | Upgrade |
Other Operating Activities | 98.02 | 85.03 | 30.02 | -1.72 | -1.65 | 5.92 | Upgrade |
Change in Accounts Receivable | -86.55 | -86.55 | 54.48 | -98.43 | -36.27 | -64.94 | Upgrade |
Change in Inventory | -21.88 | -141.49 | 13.88 | -437.82 | -218.53 | -178.51 | Upgrade |
Change in Accounts Payable | 98.06 | 98.06 | -321.54 | -72.85 | 613.39 | 268.41 | Upgrade |
Change in Other Net Operating Assets | -66.31 | 11.54 | 42.5 | 103.85 | 114.25 | - | Upgrade |
Operating Cash Flow | 518.21 | 564.51 | 699.65 | 635.19 | 1,276 | 705.12 | Upgrade |
Operating Cash Flow Growth | -33.38% | -19.32% | 10.15% | -50.22% | 80.97% | 93.24% | Upgrade |
Capital Expenditures | -415.2 | -721.39 | -1,030 | -696.41 | -784.21 | -762.77 | Upgrade |
Sale of Property, Plant & Equipment | 1.95 | 0.21 | 0 | 1.24 | 0.01 | 0.06 | Upgrade |
Cash Acquisitions | - | - | - | -155.15 | -138.09 | - | Upgrade |
Divestitures | - | - | - | 0.12 | - | - | Upgrade |
Investment in Securities | 20.48 | 227.02 | 403.67 | -11.17 | -100.1 | -606.88 | Upgrade |
Other Investing Activities | 2.6 | 32.79 | 13.78 | 25.15 | 32.53 | 38.29 | Upgrade |
Investing Cash Flow | -390.16 | -461.37 | -612.88 | -836.22 | -989.86 | -1,331 | Upgrade |
Long-Term Debt Issued | - | 149.9 | - | 137.83 | 174 | 23.84 | Upgrade |
Total Debt Issued | 317.36 | 149.9 | - | 137.83 | 174 | 23.84 | Upgrade |
Long-Term Debt Repaid | - | -160.4 | -173.91 | -84.62 | -54.32 | - | Upgrade |
Total Debt Repaid | -240.82 | -160.4 | -173.91 | -84.62 | -54.32 | - | Upgrade |
Net Debt Issued (Repaid) | 76.53 | -10.51 | -173.91 | 53.21 | 119.68 | 23.84 | Upgrade |
Issuance of Common Stock | 0 | - | 51.72 | 84.21 | - | - | Upgrade |
Repurchase of Common Stock | - | -114.08 | -105.89 | - | - | - | Upgrade |
Common Dividends Paid | -185.94 | -185.93 | -305.48 | -242.86 | -201.01 | -177.6 | Upgrade |
Other Financing Activities | 4.43 | - | 6 | -64.71 | 9.98 | -6.17 | Upgrade |
Financing Cash Flow | -104.97 | -310.52 | -527.57 | -170.16 | -71.36 | -159.94 | Upgrade |
Foreign Exchange Rate Adjustments | 22.68 | 7.81 | 10.56 | 29.56 | -19.85 | -12.35 | Upgrade |
Net Cash Flow | 45.77 | -199.57 | -430.24 | -341.63 | 194.99 | -798.48 | Upgrade |
Free Cash Flow | 103.02 | -156.88 | -330.68 | -61.22 | 491.85 | -57.65 | Upgrade |
Free Cash Flow Margin | 2.14% | -2.92% | -5.44% | -0.96% | 9.94% | -2.19% | Upgrade |
Free Cash Flow Per Share | 0.21 | -0.32 | -0.69 | -0.13 | 1.02 | -0.12 | Upgrade |
Cash Income Tax Paid | 358.69 | 480.27 | 550.54 | 770.79 | 539.9 | 369.28 | Upgrade |
Levered Free Cash Flow | -61.85 | -285.68 | -624.83 | -240.37 | 940.17 | -887.91 | Upgrade |
Unlevered Free Cash Flow | -56.98 | -279.95 | -618.13 | -231.29 | 947.09 | -887.91 | Upgrade |
Change in Working Capital | -107.49 | -137.54 | -245.63 | -567.02 | 322.66 | -25.23 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.